Loading chat...

IN SR0071

Resolution

Status

Passed

4/18/2011

Primary Sponsor

Patricia Miller

Click for details

Origin

Senate

2011 Regular Session

AI Summary

  • Urges the Legislative Council to assign the Health Finance Commission to study requiring competitive bidding among generic drug manufacturers supplying products to Medicaid recipients
  • Study would examine whether the Family and Social Services Administration should implement a competitive bidding process for generic drugs provided to Medicaid patients
  • Generic drugs offer 30% to 80% savings compared to brand name equivalents while meeting the same FDA quality and testing standards
  • Currently, Indiana's Medicaid program encourages generic drug use but does not utilize competitive bidding despite significant price variation among generic manufacturers
  • Resolution introduced during the First Regular Session of the 117th General Assembly (2011)

Legislative Description

Study of generic drug manufacturers and Medicaid recipient bidding process.

Last Action

Second reading: adopted voice vote

4/18/2011

Full Bill Text

No bill text available